Clinical Trial Management Systems Market to Surpass US$ 1.7 Billion Threshold by 2025, as Software Segment Takes Center Stage

The Global Clinical Trial Management Systems Market was valued at US$ 323.4 million in 2015 and is projected to expand at a CAGR of 13.0% during the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Pharmaceuticals manufacturers focusing on achieving first mover advantage, which in turn is projected to support growth of the clinical trial management systems market over the forecast period.

Large pharmaceutical companies have various complex and parallel functions that need to be carried out simultaneously and effectively, so as to ensure smooth functioning of all services. Such large volumes of data need to be managed and analyzed effectively, a function that is mainly outsourced to third-party organizations – a highly lucrative and fledgling sector. This poses its own set of challenges, as clinical trials are conducted across various geographic locations. Clinical trial management systems offer a highly effective solution, which allows for recording and coordinated analysis of such data through a common access point. It also helps reduce turnaround time and increases operational efficiency, while drastically reducing human error. The above mentioned factors are expected to support the growth in the clinical trial management market over the forecast period.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/212

Globally there are several healthcare IT companies who develop and modify the clinical trial management software. There are several customized software to manage clinical trials data according to client need and study protocol. According to the study conducted by the University of Minnesota and University of Michigan by 2018, all the clinical trial conducting company will use OnCore clinical trial management system as OnCore will provide the functional features such as Clinical Research Management, Study Setup, eCRFs, Financials, Visit Tracking & Data Capture, Study Data Management and Revenue Management. This is expected to be one of the crucial factors favoring the gain in traction for clinical trial management market in the near future.

There are various players in the market that are confined to their strategies and focused on the same for the growth of their products and services to favor the increase in revenue for their organization. Furthermore, the companies are equipped with various skilled employees that are continuously working on the development and advancement of such products that aligns to the need and requirement of the users. Since clinical trials are the critical process and takes a long time, which involves bundle of data sets that are to be analyzed and results are to be extracted from them. This process takes immense control of the quality and systematic behavior of the data arrangement that further helps the user to configure the procedure in the basic clinical trial activities. As part of its long-term strategy many organizations are focused towards business development activities such as acquisitions, joint ventures, technology development, and other opportunities, mainly related to acquiring companies involved in software development related to clinical trial management systems.

Key takeaways of the market:

• The global clinical trial management systems market is expected to expand at a CAGR of 13.0% during the forecast period (2016–2024). Globalization of research and development are favoring demand for software component type segment that is expected to favor the market for clinical trial management systems over the forecast period.
• The cloud-based mode of delivery segment in the global clinical trial management systems market was estimated to be the largest in 2015 and is expected to retain its dominance in the market throughout the forecast period in terms of value

To know the latest trends and insights prevalent in the clinical trial management systems market, click the link below: https://www.coherentmarketinsights.com/market-insight/clinical-trial-management-system-market-212

• In terms of end user segment, the pharmaceuticals & biotech firm is expected to expand at a significant CAGR of 12.8% during the forecast period, owing to more advanced in terms of infrastructural installations of medical systems
• The global clinical trial management systems market is characterized by Market expansion in Asia Pacific, Africa, and Middle East could generate higher market revenue due to the growing clinical research in the emerging economies
• Some of the major companies offering clinical trial management system market are Oracle Corporation, Medidata Clinical Cloud, Veeva Systems, Infosys, Bio-Optronics, BioClinica, and MedNet Solutions.

About CMI

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Clinical Trial Management System Market- Industry Analysis, Size, Share, Growth, Trends and Forecast to 2024

Clinical Trials Management System is software that helps in managing and monitoring data related to clinical trials for pharmaceutical and biotechnology companies. The core objective of clinical trial management system is to maintain a centralized database which allows users to access data at any point of time. The need for these systems stems from the growth in clinical trials over the last decade and it has become essential to manage the data in an automated manner. Clinical trials management system can be customized depending upon the users, lab requirements and nature of clinical trials.

Download Exclusive PDF Brochure of This Report: https://www.coherentmarketinsights.com/insight/request-sample/212

Growing investment in R&D by pharmaceutical players is a major driver for the clinical trial management system market

The R&D investment scenario has been positive for the pharmaceutical companies as the competition among the key players to deliver novel drugs has increased. As per data published by Industrial Research Institute, there was an increase of 3.5% in global R&D investment over 2015. The pharmaceutical companies are working on developing specialty products. For instance, Sun Pharma is expected to spend 9.1% of its revenues on R&D in 2017. Other pharma companies such as Lupin and Cipla are also expected to step up R&D investment to develop biosimilars and biobetters. The drug approval process in US has become relatively strict and pharmaceutical companies need to show better compliance and release drugs which are cost effective, beneficial and have proven results. The integration of clinical trial management systems with HIS has been an important factor for driving the market forward as integration with HIS enables the end users to access clinical data easily. Further, the rise in prevalence of chronic diseases has propelled the demand for the development of innovative drugs.

Get Exclusive Discount on this CMI Report: https://www.coherentmarketinsights.com/insight/request-discount/212

Clinical trials management system market will witness strong traction in the Asia Pacific region

North America holds the largest market share in the global clinical trial management system market accounting to growth in R&D investment by pharmaceutical companies and clinical research firms. U.S. is the hub for world’s biggest clinical research organizations and pharmaceutical companies. The healthcare industry is financing clinical trials in U.S., as the NIH funding has witnessed decline in the recent past.

Asia Pacific countries such as China, India and South Korea constitute 40% of global R&D spending. India specifically has become the hub for clinical trials and the market for it will continue to grow, as more than 130 patents will undergo expiration by 2027. Global and local pharma companies will conduct clinical trials to develop novel drugs which will make a positive impact on the clinical trial management systems market. China on the other hand has been the hub for clinical trials. As per the data published by Clinical Trials website, out of 5,552 clinical trials conducted globally, 5,045 trials were conducted in China. As the global pharmaceutical companies increase the clinical trial outsourcing to Asia Pacific countries, the clinical trial management system industry will gain rapid traction in the near future.

Browse Global Strategic Business Report: https://www.coherentmarketinsights.com/ongoing-insight/clinical-trial-management-system-market-212

The key players in the market are competing intensively by focusing on innovation and technology upgrade

The key players in the clinical trial management system market are Oracle, Parexel, Medidata Solutions, BioClinica and Bio-Optronics. The market has been in a state of consolidation with the top 4 companies accounting for more than 60% of global market share. The industry will witness the exit of players who are unable to execute seamless integration with internal and external partner systems. On the contrary, the vendors who are able to meet the needs of the end user industry effectively will continue to gain market share. The market will witness change in market dynamics as key players shift towards cloud-based model for easy data retrieval and reducing the cost of hardware.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.